Defence Therapeutics Inc. (DTC) — Financial Flexibility Index
Latest as of December 2025:
-0.54x
Defence Therapeutics Inc. (DTC) has a Financial Flexibility Index of -0.54x as of December 2025. Free cash flow of €-1.40 Million (operating CF €-1.40 Million minus capex €0.00) represents -1% of total liabilities (€2.59 Million).
Financial Flexibility Index
-0.54x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-1.40 Million
Operating CF − Capex
Total Liabilities
€2.59 Million
EUR
Capital Expenditures
€0.00
EUR
Defence Therapeutics Inc. Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Defence Therapeutics Inc. across 5 annual periods. See DTC net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Defence Therapeutics Inc. (2020–2024)
Year-by-year free cash flow to debt coverage for Defence Therapeutics Inc.. For the full company profile including market capitalisation, see DTC company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | €-4.09 Million | €-4.29 Million | €4.06 Million | ▲ +73.9% |
| 2023 | -3.86x | €-7.59 Million | €-7.66 Million | €1.97 Million | ▲ +29.3% |
| 2022 | -5.46x | €-6.04 Million | €-6.04 Million | €1.11 Million | ▲ +70.9% |
| 2021 | -18.73x | €-2.29 Million | €-2.29 Million | €122.26K | ▼ -943.1% |
| 2020 | -1.80x | €-86.81K | €-132.83K | €48.35K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities